Air Voel Expands Product Line with the Latest ResMed CPAP Machines for Enhanced Sleep Therapy.Canada - November 8, 2024 — Air ...

Air Voel believes in sleep health, offering cutting-edge CPAP devices that are reliable and adjustable for restful sleep. Air Voel allows people to manage their health with innovative technology, ...

A stellar first quarter has underscored ResMed's share price bounce-back from last year's obesity drug panic, and perhaps put ...

We forecast margin expansion as ResMed’s sales mix continues to shift to higher-margin masks and the cost inefficiency of simultaneously producing older AirSense 10 devices ceases. Our midcycle 34% ...

Q1 2025 Earnings Call Transcript October 24, 2024 ResMed Inc. beats earnings expectations. Reported EPS is $2.2, expectations ...

Financial Robustness: The financial tables from the 10-Q filing underscore ResMed Inc (NYSE:RMD)'s financial strength. With ...

ResMed is redoubling efforts to increase resupply with plans to make Snap, a software platform that monitors orders, ...

SAN DIEGO – ResMed’s revenue increased by 11% to $1.2 billion for the first quarter of 2025. It reported net income of $311.4 million, a 42% increase. “Our first-quarter fiscal year 2025 results ...

ResMed Inc.’s RMD adjusted earnings per share (EPS) in the first quarter of fiscal 2025 were $2.20, up 34.1% year over year.

Hello, and welcome to the Q1 fiscal year 2025 ResMed Earnings conference call. My name is Kevin, and I'll be your operator for today's call. (Operator Instructions) Please note this conference call is ...

Production of AirSense 11 and sales mix (between AirSense 10 and 11): "Production of AirSense 11 is firing ... and the supply chain ... ResMed is doing well, competing hard and winning accounts, ...